12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Votrient pazopanib regulatory update

GSK said it submitted a regulatory application to EMA to expand the indication of Votrient pazopanib to include maintenance treatment of patients with Stage...

Read the full 97 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >